Kurt C. Sizer
Impact in
- Infectious Diseases top 5%
- Leprosy Research and Treatment
- Tuberculosis Research and Epidemiology
- Genetics top 5%
- Hemoglobinopathies and Related Disorders
Papers in
-
- Glycosylation and Glycoproteins Research 1
-
- Leprosy Research and Treatment 4
- Co-authors
- Xiang Y. Han (4 shared papers)Wěi Li (1 shared paper)Daniele Alberti (1 shared paper)Yiel-Hea Seo (1 shared paper)Ellis J. Neufeld (1 shared paper)Taylor J. Schoberle (1 shared paper)David G. Nathan (1 shared paper)Judith R. Anderson (1 shared paper)
- Journals
- The EMBO Journal (2 papers)Clinical Cancer Research (1 paper)Cell (1 paper)Blood (1 paper)Neurocritical Care (1 paper)
- Partner nations
- United StatesSwitzerlandSpain
In The Last Decade
Kurt C. Sizer
20 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 91
- Infectious Diseases 360
- Genetics 193
- Hematology 178
- Epidemiology 248
- Immunology 132
Countries citing papers authored by Kurt C. Sizer
This map shows the geographic impact of Kurt C. Sizer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kurt C. Sizer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kurt C. Sizer more than expected).
Fields of papers citing papers by Kurt C. Sizer
This network shows the impact of papers produced by Kurt C. Sizer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kurt C. Sizer. The network helps show where Kurt C. Sizer may publish in the future.
Co-authors
The 25 scholars most cited alongside Kurt C. Sizer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 260 | |
| 2 | 2008 | 192 | |
| 3 | 2000 | 115 | |
| 4 | 2009 | 73 | |
| 5 | 1985 | 67 | |
| 6 | 1985 | 62 | |
| 7 | 2012 | 62 | |
| 8 | 1990 | 56 | |
| 9 | Identification of the leprosy agent Mycobacterium lepromatosis in Singapore. | 2012 | 36 |
| 10 | 2005 | 29 | |
| 11 | 1986 | 24 | |
| 12 | 1983 | 23 | |
| 13 | Limitation of differential expression of HLA-A,B,C antigens on choriocarcinoma cell lines by messenger RNA for HLA heavy chain but not by beta 2-microglobulin. | 1984 | 22 |
| 14 | 2010 | 18 | |
| 15 | 1994 | 14 | |
| 16 | 2007 | 9 | |
| 17 | 2001 | 3 | |
| 18 | 2008 | 1 | |
| 19 | 2005 | 1 | |
| 20 | A PK-PD dose optimization strategy for the microtubule stabilizing agent ABJ879 | 2004 | 1 |
About Kurt C. Sizer
Kurt C. Sizer is a scholar working on Molecular Biology, Infectious Diseases, Epidemiology, Surgery and Hematology, having authored 20 papers that have together received 1.1k indexed citations. Recurring topics across this work include Leprosy Research and Treatment (4 papers), Neuroblastoma Research and Treatments (2 papers), Mycobacterium research and diagnosis (2 papers), Erythropoietin and Anemia Treatment (2 papers), Click Chemistry and Applications (1 paper), Glycosylation and Glycoproteins Research (1 paper), Management of metastatic bone disease (1 paper) and T-cell and B-cell Immunology (1 paper). The work is most often cited by research in Infectious Diseases (360 citations), Genetics (193 citations), Hematology (178 citations), Epidemiology (248 citations) and Immunology (132 citations). Kurt C. Sizer has collaborated with scholars based in United States, Switzerland and Spain. Frequent co-authors include Xiang Y. Han, Wěi Li, Daniele Alberti, Yiel-Hea Seo, Ellis J. Neufeld, Taylor J. Schoberle, David G. Nathan, Judith R. Anderson, Patricia J. Giardina and Robert W. Grady. Their work appears in journals such as The EMBO Journal, Clinical Cancer Research, Cell, Blood and Neurocritical Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.